Ownership history in ORBIMED ADVISORS LLC · 22 quarters on record
This page tracks every 13F SEC filing in which ORBIMED ADVISORS LLC reported a position in APELLIS PHARMACEUTICALS INC (APLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 2,429,868 | +2,179,868 | +871.9% | 1.25% | $61.0M | $25.12 |
| 2025 Q3 | REDUCED | 250,000 | -2,073,368 | -89.2% | 0.13% | $5.7M | $22.63 |
| 2025 Q3 | ADDED | 2,323,368 | +2,273,368 | +4546.7% | 1.24% | $52.6M | $22.63 |
| 2025 Q2 | REDUCED | 50,000 | -1,432,300 | -96.6% | 0.02% | $866K | $17.31 |
| 2025 Q2 | ADDED | 1,482,300 | +50,000 | +3.5% | 0.64% | $25.7M | $17.31 |
| 2025 Q1 | ADDED | 1,432,300 | +161,900 | +12.7% | 0.75% | $31.3M | $21.87 |
| 2024 Q3 | REDUCED | 1,270,400 | -32,400 | -2.5% | 0.67% | $36.6M | $28.84 |
| 2024 Q2 | ADDED | 1,302,800 | +5,000 | +0.4% | 0.99% | $50.0M | $38.36 |
| 2024 Q1 | ADDED | 1,297,800 | +1,147,800 | +765.2% | 1.40% | $76.3M | $58.78 |
| 2024 Q1 | REDUCED | 150,000 | -772,200 | -83.7% | 0.16% | $8.8M | $58.78 |
As of 2025 Q4 — sorted by position size